Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Oct;81(3):463–468. doi: 10.1038/sj.bjc.6690716

Influence of stage at diagnosis on survival differences for rectal cancer in three European populations

E Monnet 1, J Faivre 2, L Raymond 3, I Garau 4
PMCID: PMC2362908  PMID: 10507771

Abstract

Important differences have recently been highlighted between European countries in the survival of colorectal cancer patients. As data on stage at diagnosis were available for rectal cancers in three European population-based registries (Geneva Switzerland; Côte d'Or, France; Mallorca, Spain), we compared relative survival while assessing the effect of stage in a multiple regression model. We analysed 1005 rectal cancer cases diagnosed between 1982 and 1987 and followed up for at least 5 years. In the Mallorca registry, 16% of the patients were diagnosed in the TNM stage I (versus 21% in the Côte d'Or registry and 29% in the Geneva registry, P < 10−4) and the 5-year relative survival rate was lower (35%) than in the other two registries (Côte d’Or 47%, Geneva 48%, P = 0.01). In the multivariate analysis, stage was the only independent prognostic factor, whereas the excess death risk did not vary significantly among registries (compared to Geneva, Côte d'Or relative risk was 1.0, Mallorca relative risk 1.11, 95% confidence interval 0.76–1.32 and 0.85–1.44 respectively). Survival differences between the registries were mainly due to stage at diagnosis. Thus, diagnostic conditions appear to be the main determinant of the survival inequalities found in those three European populations. © 1999 Cancer Research Campaign

Keywords: rectal neoplasm, staging, survival analysis, registries, international studies

Full Text

The Full Text of this article is available as a PDF (57.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbman G., Nilsson E., Hallbök O., Sjödahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg. 1996 Mar;83(3):375–379. doi: 10.1002/bjs.1800830326. [DOI] [PubMed] [Google Scholar]
  2. Arbman G., Nilsson E., Störgren-Fordell V., Sjödahl R. Outcome of surgery for colorectal cancer in a defined population in Sweden from 1984 to 1986. Dis Colon Rectum. 1995 Jun;38(6):645–650. doi: 10.1007/BF02054127. [DOI] [PubMed] [Google Scholar]
  3. Berrino F., Estève J., Coleman M. P. Basic issues in estimating and comparing the survival of cancer patients. IARC Sci Publ. 1995;(132):1–14. [PubMed] [Google Scholar]
  4. Blenkinsopp W. K., Stewart-Brown S., Blesovsky L., Kearney G., Fielding L. P. Histopathology reporting in large bowel cancer. J Clin Pathol. 1981 May;34(5):509–513. doi: 10.1136/jcp.34.5.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bull A. D., Biffin A. H., Mella J., Radcliffe A. G., Stamatakis J. D., Steele R. J., Williams G. T. Colorectal cancer pathology reporting: a regional audit. J Clin Pathol. 1997 Feb;50(2):138–142. doi: 10.1136/jcp.50.2.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Enblad G., Enblad P., Adami H. O., Glimelius B., Krusemo U., Påhlman L. Relationship between age and survival in cancer of the colon and rectum with special reference to patients less than 40 years of age. Br J Surg. 1990 Jun;77(6):611–616. doi: 10.1002/bjs.1800770605. [DOI] [PubMed] [Google Scholar]
  7. Feinstein A. R., Sosin D. M., Wells C. K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985 Jun 20;312(25):1604–1608. doi: 10.1056/NEJM198506203122504. [DOI] [PubMed] [Google Scholar]
  8. Gatta G., Sant M., Coebergh J. W., Hakulinen T. Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987. Eur J Cancer. 1996 May;32A(5):831–835. doi: 10.1016/0959-8049(95)00642-7. [DOI] [PubMed] [Google Scholar]
  9. Hakulinen T., Abeywickrama K. H. A computer program package for relative survival analysis. Comput Programs Biomed. 1985;19(2-3):197–207. doi: 10.1016/0010-468x(85)90011-x. [DOI] [PubMed] [Google Scholar]
  10. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982 Dec;38(4):933–942. [PubMed] [Google Scholar]
  11. Hakulinen T., Tenkanen L., Abeywickrama K., Päivärinta L. Testing equality of relative survival patterns based on aggregated data. Biometrics. 1987 Jun;43(2):313–325. [PubMed] [Google Scholar]
  12. Holm T., Johansson H., Cedermark B., Ekelund G., Rutqvist L. E. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg. 1997 May;84(5):657–663. [PubMed] [Google Scholar]
  13. Isbister W. H., Fraser J. Large-bowel cancer in the young: a national survival study. Dis Colon Rectum. 1990 May;33(5):363–366. doi: 10.1007/BF02156258. [DOI] [PubMed] [Google Scholar]
  14. Kronborg O. Staging and surgery for colorectal cancer. Eur J Cancer. 1993;29A(4):575–583. doi: 10.1016/s0959-8049(05)80155-8. [DOI] [PubMed] [Google Scholar]
  15. Kune G. A., Kune S., Field B., White R., Brough W., Schellenberger R., Watson L. F. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum. 1990 Nov;33(11):938–946. doi: 10.1007/BF02139103. [DOI] [PubMed] [Google Scholar]
  16. MacFarlane J. K., Ryall R. D., Heald R. J. Mesorectal excision for rectal cancer. Lancet. 1993 Feb 20;341(8843):457–460. doi: 10.1016/0140-6736(93)90207-w. [DOI] [PubMed] [Google Scholar]
  17. McArdle C. S., Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ. 1991 Jun 22;302(6791):1501–1505. doi: 10.1136/bmj.302.6791.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Micheli A., Capocaccia R. General mortality and its effect on survival estimates. IARC Sci Publ. 1995;(132):38–46. [PubMed] [Google Scholar]
  19. Monnet E., Faivre J., Raymond L., Garau I. Comparability of colorectal cancer survival data in three European population-based registries. Eur J Cancer Prev. 1998 Apr;7(2):127–134. [PubMed] [Google Scholar]
  20. Roncucci L., Fante R., Losi L., Di Gregorio C., Micheli A., Benatti P., Madenis N., Ganazzi D., Cassinadri M. T., Lauriola P. Survival for colon and rectal cancer in a population-based cancer registry. Eur J Cancer. 1996 Feb;32A(2):295–302. doi: 10.1016/0959-8049(95)00532-3. [DOI] [PubMed] [Google Scholar]
  21. Sant M., Capocaccia R., Verdecchia A., Gatta G., Micheli A., Mariotto A., Hakulinen T., Berrino F. Comparisons of colon-cancer survival among European countries: The Eurocare Study. Int J Cancer. 1995 Sep 27;63(1):43–48. doi: 10.1002/ijc.2910630109. [DOI] [PubMed] [Google Scholar]
  22. Simons A. J., Ker R., Groshen S., Gee C., Anthone G. J., Ortega A. E., Vukasin P., Ross R. K., Beart R. W., Jr Variations in treatment of rectal cancer: the influence of hospital type and caseload. Dis Colon Rectum. 1997 Jun;40(6):641–646. doi: 10.1007/BF02140891. [DOI] [PubMed] [Google Scholar]
  23. Smith C., Butler J. A. Colorectal cancer in patients younger than 40 years of age. Dis Colon Rectum. 1989 Oct;32(10):843–846. doi: 10.1007/BF02554552. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES